TY - JOUR
T1 - Instruments measuring the quality of life among people living with type 2 diabetes mellitus in India
T2 - A systematic review protocol
AU - Demla, Chetna
AU - Thomas, Anns
AU - Jose, Jomol
AU - Joshy, Angela L.
AU - Hrishikesh, M. A.
AU - Rajendran, Ambigai
AU - Parsekar, Shradha S.
N1 - Funding Information:
We are grateful to Manipal Academy of Higher Education (MAHE), Manipal for providing logistic support and infrastructure to carry out this systematic review. We would like to thank the faculty of PHESA, Dept. of Health Information, PSPH, MAHE, Manipal who have helped us in contributing their valuable suggestions and opinions. We would like to express our gratitude to the faculties of the Department of Commerce, MAHE, Manipal for their guidance and encouragement, which has helped us in our work. We extend our gratitude and admiration to Subrata Bhattacharya, Pharma Quant, Kolkata, West Bengal for his worthwhile inputs. We are grateful to Dr. Prachi Pundir, Research Officer, PHESA, PSPH, MAHE, Manipal for proof reading the document.
Publisher Copyright:
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
PY - 2021/4/2
Y1 - 2021/4/2
N2 - Introduction Type 2 diabetes mellitus affects an individual's quality of life (QoL); and there are multiple instruments that can be used to measure QoL. The purpose of this systematic review is to identify the existing instruments that have been used to measure QoL in people living with diabetes, and to enlist the major domains (such as physical and psychological components) available in the identified instruments. Additionally, we plan to determine the psychometric properties of the identified QoL instruments using COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) methodology. Methods and analysis The Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocol guideline was followed to report this systematic review protocol. Searches will be conducted on MEDLINE (via PubMed, Web of Science), SCOPUS and CINAHL. Predetermined inclusion/exclusion criteria will be applied to the search results, to include studies with adult individuals diagnosed with type 2 diabetes mellitus, with and without complications, and exclude studies with type 1 diabetes or other clinical illness. Studies conducted outside India will be excluded. Five authors in pairs will independently screen the articles and extract the data that meets the inclusion criteria. The COSMIN criteria will be used to assess the risk of bias of included studies. Narrative synthesis will be performed to analyse the findings of the instruments. Ethics and dissemination Ethical permission is not applicable, as this is a systematic review. We intend to disseminate the systematic review findings through a national or international conference and publish the findings in a peer-reviewed journal. PROSPERO registration number CRD42020180432.
AB - Introduction Type 2 diabetes mellitus affects an individual's quality of life (QoL); and there are multiple instruments that can be used to measure QoL. The purpose of this systematic review is to identify the existing instruments that have been used to measure QoL in people living with diabetes, and to enlist the major domains (such as physical and psychological components) available in the identified instruments. Additionally, we plan to determine the psychometric properties of the identified QoL instruments using COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) methodology. Methods and analysis The Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocol guideline was followed to report this systematic review protocol. Searches will be conducted on MEDLINE (via PubMed, Web of Science), SCOPUS and CINAHL. Predetermined inclusion/exclusion criteria will be applied to the search results, to include studies with adult individuals diagnosed with type 2 diabetes mellitus, with and without complications, and exclude studies with type 1 diabetes or other clinical illness. Studies conducted outside India will be excluded. Five authors in pairs will independently screen the articles and extract the data that meets the inclusion criteria. The COSMIN criteria will be used to assess the risk of bias of included studies. Narrative synthesis will be performed to analyse the findings of the instruments. Ethics and dissemination Ethical permission is not applicable, as this is a systematic review. We intend to disseminate the systematic review findings through a national or international conference and publish the findings in a peer-reviewed journal. PROSPERO registration number CRD42020180432.
UR - http://www.scopus.com/inward/record.url?scp=85103767084&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85103767084&partnerID=8YFLogxK
U2 - 10.1136/bmjopen-2020-043831
DO - 10.1136/bmjopen-2020-043831
M3 - Review article
C2 - 33811053
AN - SCOPUS:85103767084
SN - 2044-6055
VL - 11
JO - BMJ Open
JF - BMJ Open
IS - 4
M1 - e043831
ER -
